LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
1-Year Return
5.19%
This Quarter Return
+4.46%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$2.19B
AUM Growth
+$145M
(+7.1%)
Cap. Flow
+$1.51M
Cap. Flow
% of AUM
0.07%
Top 10 Holdings %
Top 10 Hldgs %
42.59%
Holding
1,035
New
323
Increased
120
Reduced
84
Closed
463
Top Buys
| 1 |
Walt Disney
DIS
|
+$226M |
| 2 |
Elanco Animal Health
ELAN
|
+$200M |
| 3 |
Wells Fargo
WFC
|
+$94.3M |
| 4 |
lululemon athletica
LULU
|
+$56.2M |
| 5 |
Fox Class A
FOXA
|
+$52.5M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$160M |
| 2 |
Norwegian Cruise Line
NCLH
|
+$54.4M |
| 3 |
Biogen
BIIB
|
+$39.6M |
| 4 |
Exxon Mobil
XOM
|
+$39.4M |
| 5 |
Amazon
AMZN
|
+$34.8M |
Sector Composition
| 1 | Healthcare | 19.08% |
| 2 | Communication Services | 18.75% |
| 3 | Financials | 12.66% |
| 4 | Technology | 11.22% |
| 5 | Industrials | 10.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Protagonist Therapeutics
PTGX
$3.63B
| $1.08M | 0.01% |
85,641
+68,541
| +401% | +$862K |
|
277
New York Times
NYT
$9.58B
| $1.07M | 0.01% |
+32,566
| New | +$1.07M |
|
278
Select Medical
SEM
$1.64B
| $1.06M | 0.01% |
+139,749
| New | +$1.06M |
|
279
Avient
AVNT
$3.47B
| $1.04M | 0.01% |
+35,495
| New | +$1.04M |
|
|
BT
280
DELISTED
BT Group plc (ADR)
BT
| $1.04M | 0.01% |
+70,153
| New | +$1.04M |
|
281
AAR Corp
AIR
$2.69B
| $1.03M | 0.01% |
31,791
+25,757
| +427% | +$838K |
|
282
WEX
WEX
$5.91B
| $1.02M | 0.01% |
5,330
+3,285
| +161% | +$630K |
|
283
Ultrapar
UGP
$4.09B
| $1.01M | 0.01% |
+168,794
| New | +$1.01M |
|
284
Itron
ITRI
$5.49B
| $988K | 0.01% |
+21,188
| New | +$988K |
|
285
Supernus Pharmaceuticals
SUPN
$2.58B
| $977K | 0.01% |
+27,886
| New | +$977K |
|
286
Integra LifeSciences
IART
$1.22B
| $972K | 0.01% |
17,442
+1,991
| +13% | +$111K |
|
287
MasTec
MTZ
$13.9B
| $964K | 0.01% |
20,043
+2,482
| +14% | +$119K |
|
|
SBNY
288
DELISTED
Signature Bank
SBNY
| $964K | 0.01% |
7,525
+3,846
| +105% | +$493K |
|
289
EchoStar
SATS
$24B
| $946K | 0.01% |
+32,037
| New | +$946K |
|
290
American Superconductor
AMSC
$2.26B
| $945K | 0.01% |
73,516
+60,853
| +481% | +$782K |
|
291
Watsco
WSO
$16.6B
| $937K | 0.01% |
+6,546
| New | +$937K |
|
292
Tandem Diabetes Care
TNDM
$845M
| $933K | 0.01% |
+14,700
| New | +$933K |
|
|
INST
293
DELISTED
Instructure, Inc.
INST
| $928K | 0.01% |
+19,696
| New | +$928K |
|
|
FBC
294
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $924K | 0.01% |
+28,080
| New | +$924K |
|
|
AVDR
295
DELISTED
Avedro, Inc Common Stock
AVDR
| $920K | 0.01% |
+75,000
| New | +$920K |
|
296
Ares Management
ARES
$38.7B
| $910K | 0.01% |
+39,204
| New | +$910K |
|
|
ADAM
297
Adamas Trust, Inc. Common Stock
ADAM
$659M
| $892K | 0.01% |
+36,598
| New | +$892K |
|
298
DuPont de Nemours
DD
$32.6B
| $890K | 0.01% |
8,277
-33,277
| -80% | -$3.58M |
|
|
B
299
DELISTED
Barnes Group Inc.
B
| $888K | 0.01% |
+17,272
| New | +$888K |
|
300
TherapeuticsMD
TXMD
$12.5M
| $881K | 0.01% |
+3,617
| New | +$881K |
|